$AUPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aurinia Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aurinia Pharmaceuticals Inc.. Get notifications about new insider transactions in Aurinia Pharmaceuticals Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | AUPH | Aurinia Pharmaceut ... | Martin Michael Robert | Chief Business Offi ... | Sell | S | 13.76 | 5,000 | 68,800 | 216,861 | 221.9 K to 216.9 K (-2.25 %) |
| Jun 16 2021 | AUPH | Aurinia Pharmaceut ... | Billen Daniel | Director | Option Exercise | A | 12.86 | 31,347 | 403,122 | 31,347 | |
| May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.28 | 1,600 | 18,040 | 6,000 | 4.4 K to 6 K (+36.36 %) |
| May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.26 | 1,400 | 15,764 | 4,400 | 3 K to 4.4 K (+46.67 %) |
| May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.14 | 1,000 | 11,140 | 3,000 | 2 K to 3 K (+50.00 %) |
| May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.17 | 500 | 5,585 | 2,000 | 1.5 K to 2 K (+33.33 %) |
| May 12 2021 | AUPH | Aurinia Pharmaceut ... | Donley Matthew Maxwell | Ex VP, Intern'l Ope ... | Buy | P | 10.07 | 9,900 | 99,739 | 9,900 | 0 to 9.9 K |
| May 12 2021 | AUPH | Aurinia Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Buy | P | 11.11 | 2,992 | 33,241 | 13,453 | 10.5 K to 13.5 K (+28.60 %) |
| May 12 2021 | AUPH | Aurinia Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Buy | P | 10.15 | 2,133 | 21,650 | 10,461 | 8.3 K to 10.5 K (+25.61 %) |
| May 12 2021 | AUPH | Aurinia Pharmaceut ... | Leversage Jill | Director | Buy | P | 10.96 | 2,500 | 27,389 | 3,700 | 1.2 K to 3.7 K (+208.33 %) |
| May 11 2021 | AUPH | Aurinia Pharmaceut ... | Huizinga Robert Bindert | Ex Vice President o ... | Option Exercise | M | 3.02 | 40,000 | 120,800 | 0 | |
| May 11 2021 | AUPH | Aurinia Pharmaceut ... | Huizinga Robert Bindert | Ex Vice President o ... | Buy | M | 3.02 | 40,000 | 120,800 | 143,592 | 103.6 K to 143.6 K (+38.61 %) |
| May 11 2021 | AUPH | Aurinia Pharmaceut ... | Miller Joseph M | Chief Financial Off ... | Buy | P | 9.74 | 1,000 | 9,740 | 1,000 | 0 to 1,000 |
| May 11 2021 | AUPH | Aurinia Pharmaceut ... | Miller Joseph M | Chief Financial Off ... | Buy | P | 9.74 | 1,000 | 9,740 | 1,000 | 0 to 1,000 |
| Mar 15 2021 | AUPH | Aurinia Pharmaceut ... | Solomons Neil | Chief Medical Offic ... | Option Exercise | M | 3.02 | 40,000 | 120,800 | 0 | |
| Mar 15 2021 | AUPH | Aurinia Pharmaceut ... | Solomons Neil | Chief Medical Offic ... | Sell | S | 13.49 | 40,000 | 539,600 | 187,299 | 227.3 K to 187.3 K (-17.60 %) |
| Mar 15 2021 | AUPH | Aurinia Pharmaceut ... | Solomons Neil | Chief Medical Offic ... | Buy | M | 3.02 | 40,000 | 120,800 | 227,299 | 187.3 K to 227.3 K (+21.36 %) |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Leversage Jill | Director | Buy | P | 16.03 | 1,200 | 19,236 | 1,200 | 0 to 1.2 K |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Leversage Jill | Director | Buy | P | 16.03 | 400 | 6,412 | 400 | 0 to 400 |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Option Exercise | M | 6.42 | 15,000 | 96,300 | 0 | |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Option Exercise | M | 6.06 | 30,000 | 181,800 | 0 | |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Option Exercise | M | 5.44 | 50,000 | 272,000 | 0 | |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Buy | M | 6.42 | 15,000 | 96,300 | 95,000 | 80 K to 95 K (+18.75 %) |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Buy | M | 6.06 | 30,000 | 181,800 | 80,000 | 50 K to 80 K (+60.00 %) |
| Feb 02 2021 | AUPH | Aurinia Pharmaceut ... | Hayden Michael R | Director | Buy | M | 5.44 | 50,000 | 272,000 | 50,000 | 0 to 50 K |
| Jan 29 2021 | AUPH | Aurinia Pharmaceut ... | Robertson Stephen P. | EVP, General Counse ... | Buy | P | 16.14 | 900 | 14,526 | 2,720 | 1.8 K to 2.7 K (+49.45 %) |
Page: 1